FDA approves Rockwell Medical's iron replacement drug

Jan 26 (Reuters) - The U.S. Food and Drug Administration has approved Rockwell Medical Inc's drug for treating iron loss in chronic kidney disease patients on dialysis.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.